These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8849605)

  • 1. Mechanisms of action of various ATP-sensitive potassium channel openers.
    Grover GJ
    Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
    [No Abstract]   [Full Text] [Related]  

  • 2. Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes.
    Critz SD; Liu GS; Chujo M; Downey JM
    J Mol Cell Cardiol; 1997 Apr; 29(4):1123-30. PubMed ID: 9160864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection?
    Hearse DJ
    Cardiovasc Res; 1995 Jul; 30(1):1-17. PubMed ID: 7553711
    [No Abstract]   [Full Text] [Related]  

  • 4. The ATP-regulated potassium channel in ischemia-reperfusion injury.
    Gross GJ; Yao Z; Pieper GM; Auchampach JA
    Ann N Y Acad Sci; 1994 Jun; 723():71-81. PubMed ID: 8030926
    [No Abstract]   [Full Text] [Related]  

  • 5. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
    Purcell H; Fox K
    Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
    Cavero I; Premmereur J
    Cardiovasc Res; 1994 Jan; 28(1):32-3. PubMed ID: 8111790
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation.
    Warltier DC; Auchampach JA; Gross GJ
    J Card Surg; 1993 Mar; 8(2 Suppl):279-83. PubMed ID: 8461517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

  • 9. [K-channel activators and cardioprotection].
    Specchia G; Marsico F; Laudisa ML
    Cardiologia; 1993 Dec; 38(12 Suppl 1):453-7. PubMed ID: 8020047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
    Nakaya H
    Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
    [No Abstract]   [Full Text] [Related]  

  • 11. K(+)-channel openers protect the myocardium against ischemia-reperfusion injury.
    Popescu LM; Musat S; Trifan OC; Leabu M; Tigaret CM; Popescu M; Popescu A; Hinescu ME; Moraru II; Das DK
    Ann N Y Acad Sci; 1994 Jun; 723():398-400. PubMed ID: 8030895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
    Perrone Filardi P; Chiariello M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
    [No Abstract]   [Full Text] [Related]  

  • 13. An explanation for the reported observation that ATP dependent potassium channel openers fail to mimic preconditioning.
    Grover GJ
    Cardiovasc Res; 1993 Sep; 27(9):1564. PubMed ID: 8287431
    [No Abstract]   [Full Text] [Related]  

  • 14. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
    Knight C; Purcell H; Fox K
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():229-36. PubMed ID: 7647027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving Issues in the Treatment of Ischaemic Heart Disease: The Potassium Channel Openers. Symposium proceedings. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Jul; 14 Suppl B():1-52. PubMed ID: 8103740
    [No Abstract]   [Full Text] [Related]  

  • 16. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
    Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium.
    Pomerantz BJ; Robinson TN; Morrell TD; Heimbach JK; Banerjee A; Harken AH
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):387-92. PubMed ID: 10917958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle.
    Carr CS; Yellon DM
    Basic Res Cardiol; 1997 Aug; 92(4):252-60. PubMed ID: 9342432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nicorandil, as ATP-sensitive K+ channel opener, potentiated morphine analgesia].
    Asano T; Iida H; Dohi S; Masue T; Shimonaka H
    Masui; 1996 Nov; 45(11):1342-6. PubMed ID: 8953867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial K(ATP) channel opener prevents ischemia-reperfusion injury in rat liver.
    Hai S; Takemura S; Minamiyama Y; Yamasaki K; Yamamoto S; Kodai S; Tanaka S; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):428-31. PubMed ID: 15808666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.